Introductory Clinical Pharmacology Test Bank
Overview
Pharmacology - ANS-The study of drugs and their action on living organisms.
Drug action - ANS-How the drug acts in the body; considered the most critical aspect of
pharmacology.
Clinical drug reference - ANS-A source for obtaining information about a drug and its actions.
Clinical pharmacist - ANS-A healthcare professional who provides information about drugs.
Sources for deriving medications - ANS-Plants, synthetic sources, mold, minerals, and animals.
Chemical name - ANS-A name assigned to a drug during the development process that reflects
its chemical structure.
Official name - ANS-A name assigned to a drug that is recognized by official regulatory bodies.
Pharmacologic name - ANS-A name that describes the pharmacological properties of the drug.
Trade name - ANS-A brand name assigned to a drug by its manufacturer.
Nonproprietary name - ANS-Also known as the generic name, it is a name assigned to a drug
that is not trademarked.
Drug classification - ANS-The categorization of a drug based on the chemical type of its active
ingredient or its therapeutic use.
Active ingredient - ANS-The chemical component in a drug that is responsible for its therapeutic
effects.
Food and Drug Administration (FDA) - ANS-The agency responsible for assigning categories to
newly approved drugs in the United States.
Drug name - ANS-The name by which a drug is known, which can include chemical, official,
pharmacologic, trade, and nonproprietary names.
Drug class - ANS-A category that groups drugs based on their similar properties or effects.
Drug source - ANS-The origin of a drug, which can be natural or synthetic.
,Synthetic sources - ANS-Drugs created in a laboratory setting.
Mold - ANS-A natural source from which some medications are derived.
Minerals - ANS-Natural substances that can be used as sources for medications.
Animals - ANS-Natural sources from which some medications are derived.
Nursing instructor - ANS-An educator who teaches nursing students about pharmacology and
other subjects.
Nurse assigned to the patient - ANS-A healthcare professional responsible for the care of a
specific patient.
Prescribing health care provider - ANS-A medical professional who prescribes medications to
patients.
Prescription - ANS-A category assigned by the FDA to drugs that require a licensed health care
provider's signature.
Nonprescription - ANS-A category assigned by the FDA to drugs that can be purchased without
a prescription, often referred to as over-the-counter drugs.
Controlled substance - ANS-A category assigned by the FDA to drugs that are regulated due to
their potential for abuse.
Metabolite - ANS-The inactive form of the drug.
Noncontrolled substance - ANS-A term that is not used in the context of drug classification.
Safe use of prescription drugs - ANS-Includes administering drugs, monitoring drug effects,
evaluating for toxic effects, and educating clients and caregivers about drugs.
Prescription documentation - ANS-Must contain the client's name, the name of the drug, the
dosage, the method and times of administration, and the signature of the licensed health care
provider.
Nonprescription drugs labeling requirements - ANS-Federal government has imposed labeling
requirements for OTC drugs, which should only be taken as directed on the label.
Controlled Substances Act of 1970 - ANS-Regulates the manufacture, distribution, and
dispensing of drugs classified as controlled substances.
, Manufacturing - ANS-One of the activities regulated under the Controlled Substances Act for
controlled substances.
Distribution - ANS-One of the activities regulated under the Controlled Substances Act for
controlled substances.
Dispensing - ANS-One of the activities regulated under the Controlled Substances Act for
controlled substances.
Monitoring clients for drug effects - ANS-An important responsibility of nurses to ensure the safe
use of prescription drugs.
Evaluating clients for toxic effects - ANS-An important responsibility of nurses to ensure the safe
use of prescription drugs.
Educating clients/caregivers about drugs - ANS-An important responsibility of nurses to ensure
the safe use of prescription drugs.
Dosage of the drug - ANS-A required element that must be documented in a prescription.
Route of drug administration - ANS-A required element that must be documented in a
prescription.
Times of drug administration - ANS-A required element that must be documented in a
prescription.
Licensed prescriber's signature - ANS-A required element that must be documented in a
prescription.
Over-the-counter drugs - ANS-Another term for nonprescription drugs that do not require a
prescription.
Elimination - ANS-The excretion of drugs from the body, a pharmacokinetic activity.
Orphan Drug Program - ANS-A program that encourages the development and marketing of
products to treat rare diseases.
Provisional Approval - ANS-Approval granted with a written commitment from the drug company
to formally demonstrate client benefits.
Incentives in Orphan Drug Program - ANS-Research grants, protocol assistance, and special
tax credits provided to develop products to treat rare diseases.
Overview
Pharmacology - ANS-The study of drugs and their action on living organisms.
Drug action - ANS-How the drug acts in the body; considered the most critical aspect of
pharmacology.
Clinical drug reference - ANS-A source for obtaining information about a drug and its actions.
Clinical pharmacist - ANS-A healthcare professional who provides information about drugs.
Sources for deriving medications - ANS-Plants, synthetic sources, mold, minerals, and animals.
Chemical name - ANS-A name assigned to a drug during the development process that reflects
its chemical structure.
Official name - ANS-A name assigned to a drug that is recognized by official regulatory bodies.
Pharmacologic name - ANS-A name that describes the pharmacological properties of the drug.
Trade name - ANS-A brand name assigned to a drug by its manufacturer.
Nonproprietary name - ANS-Also known as the generic name, it is a name assigned to a drug
that is not trademarked.
Drug classification - ANS-The categorization of a drug based on the chemical type of its active
ingredient or its therapeutic use.
Active ingredient - ANS-The chemical component in a drug that is responsible for its therapeutic
effects.
Food and Drug Administration (FDA) - ANS-The agency responsible for assigning categories to
newly approved drugs in the United States.
Drug name - ANS-The name by which a drug is known, which can include chemical, official,
pharmacologic, trade, and nonproprietary names.
Drug class - ANS-A category that groups drugs based on their similar properties or effects.
Drug source - ANS-The origin of a drug, which can be natural or synthetic.
,Synthetic sources - ANS-Drugs created in a laboratory setting.
Mold - ANS-A natural source from which some medications are derived.
Minerals - ANS-Natural substances that can be used as sources for medications.
Animals - ANS-Natural sources from which some medications are derived.
Nursing instructor - ANS-An educator who teaches nursing students about pharmacology and
other subjects.
Nurse assigned to the patient - ANS-A healthcare professional responsible for the care of a
specific patient.
Prescribing health care provider - ANS-A medical professional who prescribes medications to
patients.
Prescription - ANS-A category assigned by the FDA to drugs that require a licensed health care
provider's signature.
Nonprescription - ANS-A category assigned by the FDA to drugs that can be purchased without
a prescription, often referred to as over-the-counter drugs.
Controlled substance - ANS-A category assigned by the FDA to drugs that are regulated due to
their potential for abuse.
Metabolite - ANS-The inactive form of the drug.
Noncontrolled substance - ANS-A term that is not used in the context of drug classification.
Safe use of prescription drugs - ANS-Includes administering drugs, monitoring drug effects,
evaluating for toxic effects, and educating clients and caregivers about drugs.
Prescription documentation - ANS-Must contain the client's name, the name of the drug, the
dosage, the method and times of administration, and the signature of the licensed health care
provider.
Nonprescription drugs labeling requirements - ANS-Federal government has imposed labeling
requirements for OTC drugs, which should only be taken as directed on the label.
Controlled Substances Act of 1970 - ANS-Regulates the manufacture, distribution, and
dispensing of drugs classified as controlled substances.
, Manufacturing - ANS-One of the activities regulated under the Controlled Substances Act for
controlled substances.
Distribution - ANS-One of the activities regulated under the Controlled Substances Act for
controlled substances.
Dispensing - ANS-One of the activities regulated under the Controlled Substances Act for
controlled substances.
Monitoring clients for drug effects - ANS-An important responsibility of nurses to ensure the safe
use of prescription drugs.
Evaluating clients for toxic effects - ANS-An important responsibility of nurses to ensure the safe
use of prescription drugs.
Educating clients/caregivers about drugs - ANS-An important responsibility of nurses to ensure
the safe use of prescription drugs.
Dosage of the drug - ANS-A required element that must be documented in a prescription.
Route of drug administration - ANS-A required element that must be documented in a
prescription.
Times of drug administration - ANS-A required element that must be documented in a
prescription.
Licensed prescriber's signature - ANS-A required element that must be documented in a
prescription.
Over-the-counter drugs - ANS-Another term for nonprescription drugs that do not require a
prescription.
Elimination - ANS-The excretion of drugs from the body, a pharmacokinetic activity.
Orphan Drug Program - ANS-A program that encourages the development and marketing of
products to treat rare diseases.
Provisional Approval - ANS-Approval granted with a written commitment from the drug company
to formally demonstrate client benefits.
Incentives in Orphan Drug Program - ANS-Research grants, protocol assistance, and special
tax credits provided to develop products to treat rare diseases.
